Saneca Pharmaceuticals has been acquired by AZC Group

AZC Group has acquired controlling ownership of Saneca Pharmaceuticals AS, a Slovakia-based pharmaceutical contract development and manufacturing organization (CDMO).

Saneca Pharmaceuticals is a Slovakia-based pharmaceutical CDMO focused on the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients (APIs). The company operates across the pharmaceutical value chain, offering end-to-end services from product development to commercial-scale manufacturing. It serves a diversified base of pharmaceutical companies, primarily in Europe, and produces over 1,300 SKUs across a broad range of dosage forms.

AZC is a diversified industrial group headquartered in Slovakia, operating across multiple sectors including biofuels, chemicals, agriculture, transport and logistics. The group manages a portfolio of industrial assets across several countries and integrates upstream and downstream activities within its businesses.

Oaklins’ team in Slovakia acted as the sole financial advisor to the seller.